Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

Area of Science:

• Molecular Endocrinology
• Cell Signaling
• Cancer Biology

Background:

• Steroid hormones (androgens, oestrogens) regulate cell proliferation through their respective receptors.
• The Src tyrosine kinase plays a role in cellular signaling pathways.
• Cross-talk between steroid hormone receptors and Src signaling is not fully understood.

Purpose of the Study:

• To investigate the role of Src in mediating steroid hormone-stimulated proliferation in prostate and breast cancer cells.
• To elucidate the molecular mechanisms of interaction between steroid receptors and Src.
• To determine the effect of anti-steroids on hormone-induced signaling.

Main Methods:

• Treatment of LNCaP, MCF-7, and T47D cells with androgens or oestrogens.
• Assessment of receptor-Src association and Src/Raf-1/Erk-2 pathway activation.
• Microinjection of dominant-negative Src (SrcK(-)) and use of glutathione S-transferase (GST) fusion constructs in transfected Cos cells.

Main Results:

• Androgen or oestradiol treatment induced Src association with androgen receptor (AR) and oestrogen receptor beta (ERβ) in LNCaP cells, activating the Src/Raf-1/Erk-2 pathway and promoting proliferation.
• Anti-androgens and anti-oestrogens inhibited these steroid-induced effects.
• Src SH2 domain interacted with ERα phosphotyrosine 537, and Src SH3 domain with AR proline-rich region, crucial for receptor-Src association and Src activation.

Conclusions:

• Src acts as a critical mediator of both androgen and oestrogen signaling in hormone-responsive cancer cells.
• Steroid receptors directly interact with Src, leading to pathway activation and cell proliferation.
• The observed inhibition by anti-steroids suggests a complex interplay and potential therapeutic targeting opportunities.